Efficacy of anti-CD3 monoclonal antibodies in delaying the progression of recent-onset type 1 diabetes mellitus: A systematic review, meta-analyses and meta-regression.

Ashraf, Muhammad Talal; Ahmed Rizvi, Syed Hassan; Kashif, Muhammad Arham Bin; Shakeel Khan, Muhammad Khuzzaim; Ahmed, Syed Hassan; Asghar, Muhammad Sohaib

Ashraf, Muhammad Talal; Ahmed Rizvi, Syed Hassan; Kashif, Muhammad Arham Bin; Shakeel Khan, Muhammad Khuzzaim; Ahmed, Syed Hassan; Asghar, Muhammad Sohaib.

Afiliação

Ashraf MT; Department of Internal Medicine, Dow University of Health Sciences, Karachi, Pakistan.
Ahmed Rizvi SH; Department of Internal Medicine, Dow University of Health Sciences, Karachi, Pakistan.
Kashif MAB; Department of Internal Medicine, Dow University of Health Sciences, Karachi, Pakistan.
Shakeel Khan MK; Department of Internal Medicine, Dow University of Health Sciences, Karachi, Pakistan.
Ahmed SH; Department of Internal Medicine, Dow University of Health Sciences, Karachi, Pakistan.
Asghar MS; Mayo Clinic, Rochester, Minnesota, USA.

Diabetes Obes Metab ; 25(11): 3377-3389, 2023 11.

Article em En | MEDLINE | ID: mdl-37580969

Assuntos

Diabetes Mellitus Tipo 1; Humanos; Adolescente; Diabetes Mellitus Tipo 1/tratamento farmacológico; Anticorpos Monoclonais/uso terapêutico; Insulina/uso terapêutico; Doença Crônica; Peptídeo C

Palavras-chave

anti-CD3 monoclonal antibody; diabetes; otelixizumab; teplizumab

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Bases de dados: MEDLINE Assunto principal: Diabetes Mellitus Tipo 1 Tipo de estudo: Clinical_trials / Prognostic_studies / Systematic_reviews Limite: Adolescent / Humans Idioma: En Revista: Diabetes Obes Metab Assunto da revista: ENDOCRINOLOGIA / METABOLISMO Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Paquistão

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google